semaglutide dr berg Weight Loss Starter Stack Dr. Howard Berg, MD, West

Wegovy is not FDA-approved for sleep apnea only Zepbound (tirzepatide) received that indication in December 2024

When semaglutide is compounded as a salt, it can affect its safety and efficacy and may lead to dosing errors or diminished efficacy

Wegovy is intended for use in adults with obesity (body mass index [BMI] of 30 kg/m or greater) or overweight individuals (BMI of 27 kg/m or greater) with at least one weight-related comorbidity, such as type 2 diabetes or high blood pressure

Semaglutide Pharmacokinetics and Dosing - National Institutes of Health : Detailed pharmacokinetic analysis of semaglutide including half-life, steady-state concentrations, and dose-response relationships that inform titration protocols

Tirzepatide , a dual GLP-1/GIP agonist, has shown superior weight loss results in head-to-head comparisons